Amgen

Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson

Andrew Huberman

A large pharmaceutical company that is a leader in bispecific T-cell engagers ('bites'); uses AI to design synthetic proteins for cancer targeting.

346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine

Peter Attia MD

Jim Collins — Good to Great — The Knowledge Project #67

The Knowledge Project Podcast

One of the very first biotechnology companies, founded in 1976. George Rathmann, its CEO, had an incredible sense of biotech's potential and defended its patents, eventually becoming a patient of its key product, EPO.

The Science of Hunger & Medications to Combat Obesity | Dr. Zachary Knight

Andrew Huberman

A pharmaceutical company developing an antibody-based dual GLP-1 and GIP inhibitor (AMG 133) for weight loss, which can be given monthly and shows long-lasting effects.

210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.

Peter Attia MD

A pharmaceutical company that produces PCSK9 inhibitors and is developing an siRNA compound (Olpasiran) against Lp(a).